Fosfluridine tidoxilAlternative Names: Fosfluridine; HDP 99.0006; HDP 990006
Latest Information Update: 19 Apr 2011
At a glance
- Originator Heidelberg Pharma
- Class Antineoplastics; Pyrimidine nucleosides
- Mechanism of Action Thymidylate synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Suspended Actinic keratosis; Breast cancer; Colorectal cancer
Most Recent Events
- 28 Feb 2011 Heidelberg Pharma has been acquired by Wilex
- 15 Nov 2010 Suspended - Phase-II for Colorectal cancer in Germany (PO) before November 2010
- 15 Nov 2010 Suspended - Phase-II for Breast cancer in Germany (PO) before November 2010